Linnea Kristenson

ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression

R. Doebele, A. Le, R. Palmer, 2023, Proceedings of the National Academy of Sciences of the United States of America.

NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells

Ka-Wei Tang, K. Hellstrand, F. Thorén, 2023, Journal for ImmunoTherapy of Cancer.